Owners of dogs and cats with diagnosed chronic or physical conditions—kidney disease, IVDD, degenerative myelopathy, blindness, post-surgery recovery—who spend non-discretionary dollars on prescription food, adaptive gear, and targeted enrichment to extend their pet's functional life. The market is systematically underserved: products exist but are fragmented, prescription access is friction-heavy, and guidance between vet visits is nearly nonexistent.
The U.S. veterinary diet market hit $12.57B in 2026 and is growing at 7.35% CAGR through 2031, driven by rising chronic disease diagnoses that lock owners into recurring, non-negotiable prescription food spending. (Source: Mordor Intelligence, Jan 2026 — https://www.mordorintelligence.com/industry-reports/united-states-veterinary-supplements)
CKD affects up to 40% of cats over age 10 and 80% of cats over age 15, per Cornell Feline Health Center—meaning the pool of owners who need renal diets grows every year as the U.S. cat population ages into high-risk territory. (Source: Cornell University College of Veterinary Medicine — https://www.vet.cornell.edu/departments-centers-and-institutes/cornell-feline-health-center/health-information/feline-health-topics/chronic-kidney-disease)
The pet mobility aids market is valued at $312.4M in 2026 and projected to reach $661.88M by 2035 at 8.70% CAGR, accelerated by growing diagnosis of IVDD, degenerative myelopathy, and hip dysplasia in an aging dog population. (Source: MarkWide Research, May 2026 — https://markwideresearch.com/pet-mobility-aids-market)
The exact words they type into Google.
Create a free account to unlock the full breakdown — all 3 ideas and every community map on the site.
Free forever. No credit card. Takes 20 seconds.